Cheaper drugs now nearer to realization with new DropArray technology A typical laboratory tool for measuring pharmacological activity of biological chemicals and performing various other related tests may soon be changed by a fresh miniaturized bioassay that’ll be quicker, cheaper and better for scientists to use, with brand-new technology produced by Singapore’s Institute of Bioengineering and Nanotechnology online . The new assay, named DropArray, slashes the time needed to run certain lab tests by over 60 percent and decreases consumable costs by almost 90 per cent, while maintaining the same degree of flexibility and comfort as conventional platforms. According to IBN Group Leader Dr Namyong Kim, Our technology gets the potential to accelerate life science, medication discovery and clinical study.
Chemical thumbprint might help determine if tumor is dying or returning Brain tumor survivors live with the constant be concerned that their cancer might come back. And even if indeed they have a mind scan every couple of months to check, doctors often can’t tell the difference between fresh cancer growth and cells changes linked to their treatment with radiation or chemotherapy. That leaves sufferers with a difficult choice. Do they wait around and watch? Let doctors have a mind biopsy? Or, in some cases, endure another brutal round of treatment just in case the tumor has came back? But a new University of Michigan study shows that a relatively new sort of brain scan may give these individuals the reassurance – – or early warning – – that they can not get from the most common scans. Today at the annual meeting of the American Roentgen Ray Society U-M radiologists will show the evidence, a major radiology organization.